Expressing engineered thymidylate kinase variants in human cells to improve AZT 
phosphorylation and human immunodeficiency virus inhibition

Woehrl, B. M.; Loubiere, L.; Brundiers, R.; Goody, R. S.; Klatzmann, D.; Konrad, M.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Expressing engineered thymidylate kinase variants in human cells to improve AZT phosphorylation and human immunodeficiency virus inhibition

MPS-Authors

/persons/resource/persons15362

Konrad, M.
Research Group of Enzyme Biochemistry, MPI for biophysical chemistry, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Woehrl, B. M., Loubiere, L., Brundiers, R., Goody, R. S., Klatzmann, D., & Konrad, M. (2005). Expressing engineered thymidylate kinase variants in human cells to improve AZT phosphorylation and human immunodeficiency virus inhibition. Journal of General Virology, 86, 757-764. Retrieved from http://vir.sgmjournals.org/cgi/content/full/86/3/757?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&volume=86&firstpage=757&resourcetype=HWCIT.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0012-E9FD-3

Abstract

There is no abstract available